Literature DB >> 25524436

Differential associations of specific depressive and anxiety disorders with somatic symptoms.

Ella Bekhuis1, Lynn Boschloo2, Judith G M Rosmalen3, Robert A Schoevers4.   

Abstract

OBJECTIVE: Previous studies have shown that depressive and anxiety disorders are strongly related to somatic symptoms, but much is unclear about the specificity of this association. This study examines the associations of specific depressive and anxiety disorders with somatic symptoms, and whether these associations are independent of comorbid depressive and anxiety disorders.
METHODS: Cross-sectional data were derived from The Netherlands Study of Depression and Anxiety (NESDA). A total of 2008 persons (mean age: 41.6 years, 64.9% women) were included, consisting of 1367 patients with a past-month DSM-diagnosis (established with the Composite International Diagnostic Interview [CIDI]) of depressive disorder (major depressive disorder, dysthymic disorder) and/or anxiety disorder (generalized anxiety disorder, social phobia, panic disorder, agoraphobia), and 641 controls. Somatic symptoms were assessed with the somatization scale of the Four-Dimensional Symptom Questionnaire (4DSQ), and included cardiopulmonary, musculoskeletal, gastrointestinal, and general symptoms. Analyses were adjusted for covariates such as chronic somatic diseases, sociodemographics, and lifestyle factors.
RESULTS: All clusters of somatic symptoms were more prevalent in patients with depressive and/or anxiety disorders than in controls (all p<.001). Multivariable logistic regression analyses showed that all types of depressive and anxiety disorders were independently related to somatic symptoms, except for dysthymic disorder. Major depressive disorder showed the strongest associations. Associations remained similar after adjustment for covariates.
CONCLUSION: This study demonstrated that depressive and anxiety disorders show strong and partly differential associations with somatic symptoms. Future research should investigate whether an adequate consideration and treatment of somatic symptoms in depressed and/or anxious patients improve treatment outcomes.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anxiety disorders; Comorbidity; Depressive disorders; Functional somatic symptoms; Somatic symptoms

Mesh:

Year:  2014        PMID: 25524436     DOI: 10.1016/j.jpsychores.2014.11.007

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  36 in total

Review 1.  An Active Inference Approach to Interoceptive Psychopathology.

Authors:  Martin P Paulus; Justin S Feinstein; Sahib S Khalsa
Journal:  Annu Rev Clin Psychol       Date:  2019-05-07       Impact factor: 18.561

Review 2.  Functional neurological disorder and placebo and nocebo effects: shared mechanisms.

Authors:  Mark J Edwards; Michele Tinazzi; Mirta Fiorio; Miriam Braga; Angela Marotta; Bernardo Villa-Sánchez; Diletta Barbiani
Journal:  Nat Rev Neurol       Date:  2022-09-08       Impact factor: 44.711

3.  Relationship of Psychiatric Disorders and Sleep Quality to Physical Symptoms in Coronary Artery Disease.

Authors:  Anshu Peng; Ze Lin; Chunying Zhu
Journal:  J Nerv Ment Dis       Date:  2022-01-12       Impact factor: 1.899

4.  Therapeutic Alliance as Active Inference: The Role of Therapeutic Touch and Biobehavioural Synchrony in Musculoskeletal Care.

Authors:  Zoe McParlin; Francesco Cerritelli; Giacomo Rossettini; Karl J Friston; Jorge E Esteves
Journal:  Front Behav Neurosci       Date:  2022-06-30       Impact factor: 3.617

5.  The role of gender and anxiety in the association between somatic diseases and depression: findings from three combined epidemiological studies in primary care.

Authors:  E Asselmann; J Venz; L Pieper; H-U Wittchen; D Pittrow; K Beesdo-Baum
Journal:  Epidemiol Psychiatr Sci       Date:  2017-11-09       Impact factor: 6.892

6.  Acute and repeated exposure to social stress reduces gut microbiota diversity in Syrian hamsters.

Authors:  Katherine A Partrick; Benoit Chassaing; Linda Q Beach; Katharine E McCann; Andrew T Gewirtz; Kim L Huhman
Journal:  Behav Brain Res       Date:  2018-02-21       Impact factor: 3.332

7.  From psychological to physical health: Exploring temporal precedence throughout emotion regulation therapy.

Authors:  Megan E Renna; Mia S O'Toole; David M Fresco; Richard G Heimberg; Douglas S Mennin
Journal:  J Anxiety Disord       Date:  2021-04-15

8.  Comorbid Anxiety and Depression, Though Underdiagnosed, Are Not Associated with High Rates of Low-Value Care in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Matthew F Griffith; Hung-Yuan P Chen; David B Bekelman; Laura C Feemster; Laura J Spece; Lucas M Donovan; David H Au; Evan P Carey
Journal:  Ann Am Thorac Soc       Date:  2021-03

Review 9.  Respiratory therapy for the treatment of anxiety: Meta-analytic review and regression.

Authors:  Teresa M Leyro; Mark V Versella; Min-Jeong Yang; Hannah R Brinkman; Danielle L Hoyt; Paul Lehrer
Journal:  Clin Psychol Rev       Date:  2021-01-24

10.  Psychiatric morbidity, somatic comorbidity and substance use in an adolescent psychiatric population at 3-year follow-up.

Authors:  Kari Skulstad Gårdvik; Marite Rygg; Terje Torgersen; Stian Lydersen; Marit Sæbø Indredavik
Journal:  Eur Child Adolesc Psychiatry       Date:  2020-07-15       Impact factor: 4.785

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.